The AEBP1 gene helps your body organize collagen, a key support protein in connective tissue. This gene plays an important role in keeping skin, joints, and other tissues strong and flexible. When it does not work properly, these tissues may be more fragile or stretchy than usual, which can lead to very flexible joints, easy bruising, poor wound healing, and soft or delicate skin. Pathogenic variants in the AEBP1 gene are linked to a rare inherited form of Ehlers-Danlos syndrome.
What is a gene?
Genes are stretches of DNA that carry instructions cells use to make molecules or manage activities in the body. Some genes provide the directions for producing proteins, which do much of the cell’s work. Others mainly regulate when, where, and how much certain activities take place. Taken together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medicines. More detail is available in the LearnHub.
Overview
AEBP1Gene function
What if the gene works
The AEBP1 gene helps build and organize connective tissue, the material that supports skin, joints, and blood vessel walls. Its protein supports collagen fibers and helps tissues stay strong and flexible.
Risk
What if the gene does not work
When the AEBP1 gene does not work properly, people can develop a classical-like Ehlers-Danlos syndrome, with stretchy skin, easy bruising, and flexible joints. Milder or more severe variants can influence which features appear and how pronounced they are.
Treatment
What does that mean for your treatment
No AEBP1-specific treatment or drug choice approach is currently established for pathogenic variants in the AEBP1 gene. AEBP1 is being studied as a biomarker and possible drug target in some cancers and fibrotic conditions.
Conditions associated with AEBP1
Gene function
What if the gene works
Your skin, joints, and other supportive tissues depend on well-ordered collagen to stay strong and flexible. The AEBP1 gene helps your body build and organize this connective tissue framework. When it is working normally, tissues can hold together and respond to everyday stretching and repair.
The AEBP1 gene makes a protein that attaches to collagen and helps organize it outside cells. This supports the strong, flexible framework that skin, tendons, and other connective tissues need.
This protein supports the extracellular matrix (the material around cells) that helps tissues keep their shape. That is a key part of what the AEBP1 gene does in connective tissue throughout the body.
Inside some cells, its protein also helps regulate gene activity, meaning it influences when certain genes are turned on or off. This helps coordinate normal connective tissue building and remodeling over time.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These changes are common and help create normal human diversity, such as differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not cause any noticeable effect and simply reflect natural genetic variation. In some situations, though, a variant can change the function of a gene more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Many AEBP1 gene variants reduce how much working ACLP protein cells make or release into the supportive material around them. More disruptive changes, such as early stop or splice variants, often leave little or no functional protein, while milder missense variants may allow partial activity. This range helps explain how AEBP1 gene variants affect connective tissue, and variants that remove more function are often linked to earlier or more noticeable features.
How variants are linked to conditions
Pathogenic variants in the AEBP1 gene cause classical-like Ehlers-Danlos syndrome type 2, a connective tissue condition linked with very stretchy skin, easy bruising, poor wound healing, and loose joints. This AEBP1 gene link to Ehlers-Danlos syndrome is the main well-established association in human genetics. People diagnosed through testing usually have pathogenic variants in both copies of the gene.
A variant is not necessarily a diagnosis
Variants in genes are a usual feature of human biology and are widely found across the general population. Most do not directly affect health and instead reflect normal human diversity. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when several genes and environmental influences play a role. In some situations, though, one well understood variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There isn’t yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the AEBP1 gene. For many living with an AEBP1-related condition, risk is shaped mainly by the gene change itself, while day-to-day care focuses on watching for symptoms and preventing complications.
Inheritance of AEBP1 variants
AEBP1-related conditions with a well-established inheritance pattern are inherited in an autosomal recessive way. This means a person usually has to inherit two disease-causing variants in the AEBP1 gene, one from each parent, to be affected. Parents who each carry one variant are often unaffected carriers. For families asking about the AEBP1 inheritance pattern, each pregnancy between two carriers has a 25% chance of an affected child, a 50% chance of a child who is a carrier, and a 25% chance of a child with neither variant.
What does my AEBP1 result mean for my family?
For AEBP1, the best-known family pattern is recessive, which means close relatives may want to know whether they also carry the gene change. Brothers and sisters can sometimes have the same condition, even if parents have never had symptoms, and parents are often healthy carriers. Children of someone with an AEBP1-related condition are usually carriers unless the other parent also carries an AEBP1 change.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the AEBP1 gene, genetic testing analyzes DNA from a blood sample, saliva, or cheek swab for changes in the gene sequence. AEBP1 genetic testing is often part of a connective tissue panel or broader sequencing test, and results classify any variant by the strength of the evidence.
When should I consider getting a genetic test?
Consider AEBP1 testing if you or a close relative has signs of a rare inherited connective tissue condition, such as very stretchy or fragile skin, easy bruising, poor wound healing, or unusually loose joints. Testing may also help clarify the cause when doctors suspect a form of Ehlers-Danlos syndrome linked to AEBP1.
A genetic result is only one part of your health story
A genetic result can provide helpful insight, but what it shows depends on the condition and the type of variant involved. Lifestyle, environment, age, and medical history are among the many factors that shape how the body functions over time. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best understood as part of the broader picture of care. In other situations, a genetic result can offer a clear answer. In areas like medication response, genetic results can also help put personal experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same treatment works well for one person, seems weaker for another, or causes more side effects in someone else. Small differences in how the body breaks down, moves, or responds to a drug are common, and they can influence both benefit and sensitivity.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in genes affect the way people respond to medicines. It studies links between genes and medications to help explain why the same treatment can work differently in different people. For many drugs, genes influence how strongly a medicine works or how the body handles it. This information can support more informed, more individualized treatment decisions. To explore this topic in more detail, you can learn more in the LearnHub.
Drugs influenced by the AEBP1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding how medicines are chosen or used. Questions about side effects, treatment changes, or your overall health are best discussed with your doctor.